Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2024-04-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
2023年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2023 年度董事会工作报告' which translates to '2023 Annual Board of Directors Work Report'. It details the board's activities, strategic decisions, governance, risk management, and operational oversight throughout the year 2023. It includes summaries of board meetings, resolutions passed, and plans for 2024. The content focuses on the board's role in strategy, decision-making, and risk prevention rather than presenting full financial statements or audit results. It is not a full annual report (10-K), audit report (AR), or earnings release (ER). It is a detailed report on board and management activities and governance. Therefore, the document fits best under 'Board/Management Information' (MANG). The document length (5960 characters) supports it being a substantive report rather than a brief announcement or certification. Hence, the classification is MANG with high confidence.
2024-04-24 Chinese
关于公司2024-2025年度向中粮财务有限责任公司申请不超过41亿元综合授信的关联交易公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a related-party transaction where the company is applying for a credit facility (up to 4.1 billion RMB) from an affiliated financial company controlled by the same parent company. It details the transaction overview, related parties, terms, pricing policy, approvals, and independent director opinions. The document is relatively short (1667 characters) and focuses on a specific financing transaction announcement rather than a full financial report or detailed financial statements. There is no indication of comprehensive financial data or a full report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2024-04-24 Chinese
2023年度独立董事述职报告（任发政）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2023 from a company's independent director. It details the director's attendance at board meetings, opinions on various company matters, participation in board committees, and efforts to protect shareholder interests. The content focuses on governance activities and the independent director's role and opinions rather than financial data or audit results. It is not an annual report, audit report, or earnings release. It is a report related to board/management information, specifically about the independent director's duties and opinions. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short (1810 characters), but it contains substantive content about management and board activities, not just an announcement or certification, so it is not RPA or RNS.
2024-04-24 Chinese
2024年度日常关联交易预计情况的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from 中粮生物科技股份有限公司 (COFCO Biotechnology Co., Ltd.) regarding the company's 2024年度日常关联交易预计情况 (2024 annual expected related party transactions) and actual related party transactions for 2023. It includes extensive tables listing transaction categories, counterparties, pricing principles, contract amounts, and actual amounts for related party purchases and sales. The document also describes the approval process by the board and shareholders, including independent directors' opinions and voting procedures. There is no indication that this is a full annual report, audit report, earnings release, or other financial statement. Instead, it is a regulatory disclosure focused on related party transactions, which is a common regulatory filing in Chinese markets to ensure transparency of related party dealings. The document is lengthy (15,000 characters) and contains substantive data about related party transactions, not just an announcement of a report or a certification. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a regulatory announcement about related party transactions that does not fit into other specific categories like Annual Report or Audit Report.
2024-04-24 Chinese
2023年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for the fiscal year 2023 of 中粮生物科技股份有限公司. It contains detailed audit opinions, basis for audit opinions, key audit matters, management and governance responsibilities, and extensive financial statements including balance sheets, income statements, cash flow statements, and notes. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with a standalone audit report rather than a full annual report or other filing types. There is no indication that this is a certification letter or a report publication announcement. Therefore, the document fits the category of Audit Report / Information (AR). FY 2023
2024-04-24 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "中粮生物科技股份有限公司2024 年第一季度报告" which translates to "COFCO Bio-chemical Co., Ltd. 2024 First Quarter Report." It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes on non-recurring items. The report explicitly states it is a quarterly report and is unaudited. The length of the document (12,415 characters) and the presence of comprehensive financial statements and analysis confirm it is a substantive financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.